Indication

Obesity due to proopiomelanocortin (POMC) deficiency

Obesity due to proopiomelanocortin (POMC) deficiency is an extremely rare, autosomal recessive monogenic obesity disorder affecting the central nervous and endocrine systems. Read more about Obesity due to proopiomelanocortin (POMC) deficiency

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Obesity due to proopiomelanocortin (POMC) deficiency therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Obesity due to proopiomelanocortin (POMC) deficiency preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Obesity due to proopiomelanocortin (POMC) deficiency.

Obesity due to proopiomelanocortin (POMC) deficiency is an extremely rare, autosomal recessive monogenic obesity disorder affecting the central nervous and endocrine systems.

It is caused by homozygous or compound heterozygous loss-of-function variants in the *POMC* gene, which impairs the synthesis of key downstream cleavage peptides including alpha-melanocyte-stimulating hormone (a-MSH) and adrenocorticotropic hormone (ACTH).

Loss of a-MSH signaling at hypothalamic melanocortin-4 receptors (MC4R) disrupts central satiety and energy balance regulation, resulting in intractable, early-onset hyperphagia and severe pediatric obesity typically established within the first year of life.

Co-occurring features often include secondary adrenal insufficiency from ACTH deficiency—frequently presenting in infancy with hypoglycemia, seizures, or cholestasis—and hypopigmentation manifesting as pale skin and red hair due to absent melanocortin-1 receptor stimulation.

Personalize your experience

Follow Obesity due to proopiomelanocortin (POMC) deficiency and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it